Reliability, speed and ease of use of antibody tests are key to minimizing risk and saving lives.
The mobile antibody rapid tests are designed to provide precise results in the shortest possible time. They are suitable wherever a large number of people have to be tested quickly: in hospitals, laboratories, medical practices, prisons, at the point of care (POC), airports and in many other areas where the risk of infection needs to be minimized.
As a sales partner of MedMira Inc., Convirm DX AG also gives the European market access to the vital tests.
Drop the sample (blood, serum, plasma) onto the test membrane, place the InstantGold Cap on the cartridge and add the reagent liquid.
The result is displayed immediately.
This simple and quick application enables testing on a very large scale and without prior concrete suspicion. Such tests are essential to control the spread of dangerous diseases at an early stage and to prevent possible epidemics/pandemics.
In contrast to most other antibody tests, REVEALCOVID-19™ does not just test a few antibodies, but all those that are relevant to SARS-CoV-2. Such a total antibody test therefore has a significantly higher accuracy and significance.
These serological antibody tests are based on the patented Rapid Vertical Flow® technology from the Canadian company MedMira. MedMira provides fast and accurate results for a range of antibody tests such as hepatitis B and C, HIV 1/2, syphilis and now also SARS-CoV-2.
In 3 minutes from unpacking to the result.
Extremely high responsiveness.
Reliable test results with every use.
In just three steps to the result.
It doesn’t need any additional devices.
REVEALCOVID-19™ Total Antibody Test provides instant results without additional equipment. Since it tests all antibodies relevant to SARS-CoV-2 at the same time, it has a significantly higher sensitivity than comparable tests.
This SARS-CoV-2 antibody test is used wherever large numbers of people need to be tested quickly. It was developed to relieve medical professionals and to meet the high demand.
Reveal is the next generation of rapid HIV tests that use MedMira’s patented Rapid Vertical Flow® (RVF) technology.
Reveal can test whole blood using fingersticks and venipuncture, enabling patients to be tested not only in laboratories and hospitals, but also at the point-of-care.
Quality antibody testing is urgently needed due to shrinking healthcare budgets and resources. With the unique ability to display multiple results on one test device with just one drop of sample, Multiplo® tests offer a new class of rapid testing solution.
A large number of donors are HIV or hepatitis positive. Tissue and eye banks are therefore dependent on this status being recognized as quickly as possible. Miriad tests HIV-1/2, hepatitis B and C, and syphilis antibodies in cadaver blood, providing immediate, easy-to-interpret results.
MedMira’s patented Rapid Vertical Flow® (RVF) technology makes it possible to capture different biomarkers on a single carrier membrane and thus obtain multiple results simultaneously. Such combined antibody tests increase the efficiency and accuracy of rapid serological tests enormously.
In a globally networked world, the healthcare system will be confronted with new, unprecedented challenges in the future. Efficient and fast mass tests are becoming increasingly important in order to detect possible diseases at an early stage and to prevent epidemics or even pandemics.
Not only hygiene standards, distance rules or protective measures such as masks and gloves can reduce the risk of infection. Knowledge of possible diseases and immunities can also significantly improve occupational safety.
Wiggenweg 3
9404 Rorschacherberg, Switzerland
Tel: +41 71 855 07 49
Mail: office@convirmdx.com
The rapid test technology for the 21st century.
Reliability, speed and ease of use of antibody tests are key to minimizing risk and saving lives.